The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the United States District Court for the Western District of Pennsylvania on behalf of investors who purchased Mylan N.V. (NASDAQ: MYL) securities between May 9, 2018 and May 6, 2019.
According to the Mylan lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (1) Mylan’s Morgantown facility was in significant violation of the FDA’s Current Good Manufacturing Practice regulations; (2) Mylan would need to engage in a massive restructuring and remediation program; (3) Mylan’s North American Segment would be substantially impacted by said program, which would in turn materially impact Mylan’s financial health; (3) Mylan lacked effective internal control over financial reporting; and (4) as a result of the foregoing, the Company’s financial statements were materially false and misleading at all relevant times.
If you suffered a loss in Mylan you have until February 14, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
To receive more information, please fill out the form.